Hypertension, Vol 14, 488-497, Copyright © 1989 by American Heart Association
PC Wong, TM Reilly and PB Timmermans
A specific angiotensin II monoclonal antibody, KAA8, was used to examine
the interaction between sympathetic function and angiotensin II in pithed
rats. KAA8, at 5 or 50 mg/kg i.v., did not alter the mean blood pressure,
cardiac output, total peripheral resistance, or heart rate responses to
sympathetic neural stimulation (0.25-4.0 Hz) or to norepinephrine (0.3-3
micrograms/kg i.v.) but blocked significantly the hemodynamic responses to
angiotensin II (0.03-1.0 microgram/kg i.v.) and to angiotensin III (0.3-10
micrograms/kg i.v.). KAA8 treatment also reduced the plasma immunoreactive
angiotensin II from 2,880 +/- 475 pg/ml to an undetectable level. In
contrast, captopril (5 mg/kg i.v.) and saralasin (10 or 50
micrograms/kg/min i.v.) inhibited the mean blood pressure and total
peripheral resistance responses, but not the cardiac output and heart rate
responses, to sympathetic neural stimulation and to norepinephrine. These
results, which confirm previous findings by Kaufman and Vollmer (Kaufman
LJ, Vollmer RR: Endogenous angiotensin II facilitates sympathetically
mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther
1985;235:128- 134), demonstrate that angiotensin II selectively potentiates
the sympathetic vascular function in the pithed rat. However, our results
suggest that circulating angiotensin II does not appear to interact with
the sympathetic vascular function. It is speculated that in the pithed rat
the sympathetic vascular response is enhanced by vascular- formed
angiotensin II.
ARTICLES
Effect of a monoclonal antibody to angiotensin II on hemodynamic responses to noradrenergic stimulation in pithed rats
Medical Products Department, E.I. du Pont de Nemours & Company, Inc., Wilmington, DE 19880-0400.
This article has been cited by other articles:
![]() |
M. Boddi, L. Poggesi, M. Coppo, N. Zarone, S. Sacchi, C. Tania, and G. G. N. Serneri Human Vascular Renin-Angiotensin System and Its Functional Changes in Relation to Different Sodium Intakes Hypertension, March 1, 1998; 31(3): 836 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Erdmann, K. Fuxe, and D. Ganten Subcellular Localization of Angiotensin II Immunoreactivity in the Rat Cerebellar Cortex Hypertension, November 1, 1996; 28(5): 818 - 824. [Abstract] [Full Text] |
||||
![]() |
A. Moriguchi, E. A. Tallant, K. Matsumura, T. M. Reilly, H. Walton, D. Ganten, and C. M. Ferrario Opposing Actions of Angiotensin-(1-7) and Angiotensin II in the Brain of Transgenic Hypertensive Rats Hypertension, June 1, 1995; 25(6): 1260 - 1265. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |